Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
HumanaMedicare Advantage · Prior Auth · Medicaid · FL, KY, SC, VA · Oncology, Nuclear MedicineHigh impact

Lutathera (lutetium Lu 177 dotatate) (Revised)

Act
by Aug 26, 2026
Effective date
Aug 26, 2026
Identified
Aug 25, 2026

Summary

This is a revised Lutathera (lutetium Lu 177 dotatate) prior authorization policy effective August 26, 2026, for Medicare and four state Medicaid programs (FL, KY, SC, VA). The policy clarifies three mandatory approval criteria: diagnosis of unresectable/metastatic neuroendocrine tumors, somatostatin receptor-positive imaging, and no prior Lutathera therapy (maximum 4 doses). The revision includes detailed dose modification protocols for adverse reactions (thrombocytopenia, anemia, neutropenia, renal/hepatic toxicity, hypersensitivity), mandatory premedication/concomitant medication requirements (long-acting octreotide timing, amino acid infusions), and comprehensive warnings regarding radiation exposure, myelosuppression, and secondary malignancy risk.

Get alerts when payers change rules like this one

We check Humana and other payers every day and email you when a change matches your specialty and state.

Get Humana alertsPolicy Monitoring is free. No card required.

What to do

by Aug 26, 2026 · 11 steps
01Billing and prior authorization teams must update all systems and workflows to reflect this revised Lutathera policy across Medicare and Medicaid programs in FL, KY, SC, and VA.
02Update prior authorization workflows to require and verify all three approval criteria before processing claims.
03Implement dose modification logic in billing/claims systems to flag claims exceeding maximum 4 doses within 8-week intervals for review.
04Modify encounter templates and clinical documentation requirements to capture somatostatin receptor imaging results and specific NET diagnosis details (gastroenteropancreatic, lung, thymus, pheochromocytoma/paraganglioma).
05Train prior authorization staff on mandatory premedication requirements (long-acting octreotide timing: discontinue 4 weeks pre-treatment, administer 4-24 hours post-dose, continue up to 18 months post-treatment) and amino acid infusion protocols (L-lysine/L-arginine starting 30 minutes before Lutathera).
06Create decision trees in PA system for dose modifications based on adverse reaction severity (first occurrence Grade 2-4 thrombocytopenia = hold until resolution; recurrent Grade 2-4 = permanent discontinuation).
07Flag all claims for monitoring of long-term toxicity risks including MDS/leukemia and renal impairment.
08WHO: Prior authorization team, billing team, claims processors, and clinical reviewers.
09WHERE: Update in billing software, claims adjudication system, PA portal, and EMR templates.
10CONSEQUENCE: Claims submitted without proper prior authorization or missing required documentation (imaging confirmation, diagnosis specificity, prior therapy verification) will be denied.
11Off-label dosing or failure to implement dose modifications will result in claim denials and potential fraud/abuse issues.

Codes mentioned

J3302

Original notice

Lutathera (lutetium Lu 177 dotatate) (Revised)
mcp.humana.com · Always check the source before changing claims.
View original ↗

Related changes

See all Humana changes →
Lutathera (lutetium Lu 177 dotatate) (Revised)MediumEffective Nov 1, 2025 · MedicaidLutathera (lutetium Lu 177 dotatate) (Revised)MediumEffective Oct 8, 2025 · MedicaidLutathera (lutetium Lu 177 dotatate) (New)MediumEffective Nov 1, 2025 · MedicaidBrowse every Humana change in the policy list

Related policy hubs

Humana policiesFL policy changesKY policy changesSC policy changesVA policy changesOncologyNuclear MedicineCode J3302

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account